Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-035619
Filing Date
2024-03-18
Accepted
2024-03-18 17:00:12
Documents
1
Period of Report
2024-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm249079d1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm249079d1_4seq1.xml 4 7277
  Complete submission text file 0001104659-24-035619.txt   8908
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 60 JUBILEE AVENUE, MILTON PARK ABINGDON OXFORDSHIRE X0 X0 OX14 4R
Business Address
Piccina Cintia (Reporting) CIK: 0001907199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 24759865